Brimonidine-purite 0.1% versus brimonidine-purite 0.15% twice daily in glaucoma or ocular hypertension: a 12-month randomized trial*

By Cantor† Louis B.   Safyan Eleonora   Liu Ching-Chi   Batoosingh Amy L.  

Current Medical Research and Opinion, Vol. 24, Iss. 7, 2008-07 ,pp. : 2035-2043

Informa Healthcare

Access to resources Recommend Favorite

Brimonidine purite 0.1% versus brinzolamide 1% as adjunctive therapy to latanoprost in patients with glaucoma or ocular hypertension

By Day Douglas G.   Hollander David A.  

Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. : 1435-1442

Informa Healthcare

Access to resources Recommend Favorite

Efficacy, Safety, and Tolerability of Telcagepant in the Treatment of Acute Migraine: A meta‐Analysis

By  

PAIN PRACTICE, Vol. 15, Iss. 2, 2015-02 ,pp. : 124-131

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of brimonidine and dorzolamide for intraocular pressure lowering in glaucoma and ocular hypertension

By Katz L. Jay   Simmons Steven T.   Craven E. Randy  

Current Medical Research and Opinion, Vol. 23, Iss. 12, 2007-12 ,pp. : 2971-2983

Informa Healthcare

Access to resources Recommend Favorite

Systematic review and meta-analysis of the clinical safety and tolerability of ibuprofen compared with paracetamol in paediatric pain and fever

By Southey Elizabeth R.   Soares-Weiser Karla   Kleijnen Jos  

Current Medical Research and Opinion, Vol. 25, Iss. 9, 2009-09 ,pp. : 2207-2222

Informa Healthcare

Access to resources Recommend Favorite